Researchers at the University of Connecticut have developed CARRD, a novel RNA detection method that operates at room temperature without pre-amplification, achieving attomolar sensitivity for viral diagnostics. The technique detected HIV and hepatitis C virus RNA at concentrations 10,000 times lower than standard CRISPR tests, potentially transforming point-of-care diagnostics in resource-limited settings.
Open-science publisher Frontiers has launched FAIR² Data Management, an integrated platform designed to address the significant challenge of scientific data loss and underutilisation. The service combines artificial intelligence with established data management protocols to streamline how research data is stored, shared, and reused across scientific disciplines.
Scientists at the University of Cambridge have created three-dimensional embryo-like structures from human stem cells that spontaneously produce blood cells, offering a new window into early human development and a potential source of cells for transplantation. The structures, called ‘hematoids’, develop beating heart cells and blood stem cells without requiring the complex cocktails of growth […]
INTEGRA Biosciences has introduced the SWITCH hybrid pipette, a laboratory instrument scientifically evaluated for ergonomics through collaboration with the Zurich University of Applied Sciences (ZHAW). The device combines manual pipetting control with electronic repeat dispense functionality, addressing workplace injury risks associated with repetitive laboratory tasks.
Revvity has introduced Living Image Synergy AI, a unified software platform designed to streamline preclinical imaging analysis across multiple modalities. The solution integrates artificial intelligence capabilities to enhance data analysis for in vivo imaging researchers working with optical, microCT, ultrasound, and other imaging technologies.
Siemens Healthineers has introduced the Atellica DT 250 Analyzer, a benchtop drug testing system designed to deliver clinical-quality results across diverse testing environments, from forensic laboratories to hospital settings.
Cambridge-based Abselion has introduced a Protein G Total Antibody Quantification Kit for its Amperia benchtop platform, extending the system’s analytical capabilities beyond existing Protein A-based formats. The kit enables researchers to quantify antibodies across a broader spectrum of IgG subclasses and species, addressing measurement gaps in humanised antibodies, rodent IgGs, and engineered variants.
HemostOD, a Swiss preclinical-stage company developing ex vivo manufactured universal human blood platelets, has closed a CHF 4.3 million seed extension financing round to advance pre-IND development and establish commercial-scale production capabilities. The funding round was co-led by Polytech Ventures and Orenok Holdings, with participation from the Lichtsteiner Foundation and private investors.
San Diego biotech company Replicate Bioscience has entered into a multi-year research collaboration with pharmaceutical giant Novo Nordisk to develop self-replicating RNA (srRNA) therapeutics targeting obesity, type 2 diabetes, and other cardiometabolic conditions. The partnership combines Replicate’s proprietary srRNA platform technology with Novo Nordisk’s expertise in metabolic disease to create a new class of therapeutic […]
Integrated DNA Technologies (IDT) has announced a strategic partnership with Hamilton Company to develop automated comprehensive genomic profiling workflows for cancer research and other genomic applications. The collaboration will integrate IDT’s customisable NGS research components with Hamilton’s precision liquid handling platforms.
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
